DOI: http://dx.doi.org/10.18203/2349-3933.ijam20213702

The incidence of osteoporosis and vertebral fracture in women with postmenopausal type 2 diabetes mellitus and predisposing factors of vertebral fractures

Tugcan Alp Kirkizlar, Mehmet Burak Aktuglu

Abstract


Background: Type 2 diabetes mellitus (DM) has an increased fracture risk due to loss of bone quality and tendency to falling. The aim of the study was to analyze the incidence of osteoporosis and vertebral fractures (VF) in postmenopausal women with type 2 DM and to define the risk factors of VF in terms of clinical, metabolic characteristics and diabetes related microvascular complications.

Methods: The 42 postmenopausal patients with type 2 DM were included to the study in Haseki Training and Research Hospital outpatient clinics.

Results: Osteoporosis with regard to lumbar spine (LS) and femur neck (FN) was 8.4%, 19.4%, respectively. Vertebral fracture ratio was 31%. There was no statistical significance between vertebral fracture and osteoporosis. In logistic regression analysis, longer postmenopausal period, higher postprandial blood glucose (PBG), presence of peripheral neuropathy was found associated with vertebral fracture (p=0.04, 0.04, and 0.05, respectively).

Conclusions: In this study we suggest to consider the length of postmenopausal period, PBG and peripheral neuropathy for assessing the risk of VF.


Keywords


Menopause, Type 2 DM, Fracture, Vertebrae

Full Text:

PDF

References


Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S. Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res. 2008;23(8):1334-42.

Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(3):1013-19.

Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes -a meta-analysis. Osteoporos Int. 2007;18(4):427-44.

Wongdee K, Charoenphandhu N. Update on type 2 diabetes-related osteoporosis. World J Diabetes. 2015;6(5):673-8.

Zhou Y, Li Y, Zhang D, Wang J, Yang H. Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract. 2010;90:261-9.

Viégas M, Costa C, Lopes A, Griz L, Medeiro MA, Bandeira F. Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications. J Diabetes Complications. 2011;25(4):216-21.

Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375-82.

Jackuliak P, Payer J. Osteoporosis, Fractures, and Diabetes. Int J Endocrinol. 2014;2014:820615.

The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289(19):2560-71.

Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486-97.

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-47.

World Health Organization. Assessment of fracture risk and its application to screening fot postmenopausal osteoporosis. Report of a WHO Study Group. 1994. Technical Report Series 843, Geneva, Switzerland.

Genant HK, Wu CY, van Kuijik C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-48.

Al-Maatouq MA, El-Desouki M, Othman SA, Mattar EH, Babay ZA, Addar M. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus. Saudi Med J. 2004:25(10):1423-7.

Anaforoğlu I, Nar-Demirer A, Bağçıl-Tütüncü N, Ertörer ME. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes. J Diabetes Complications. 2009;23(1):12-7.

Raska I Jr, Raskova M, Zikan V, Skrha J. Prevalence and risk factors of osteoporosis in postmenopausal women wıth type 2 diabetes mellitus. Cent Eur J Public Health. 2017;25(1):3-10.

Valerio G, Del Puente A, Esposito –del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res. 2002;58(6):266-72.

Nicodemus KK, Folsom AR. Type 1 and Type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001;24(7):1192-7.

Jung JK, Kim HJ, Lee HK, Kim SS, Shin CS, Tim JT. Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea. Diabetes Metab J. 2012;36(2):144-50.

Nelson DA, Jacober SJ. Why do older women with diabetes have an increased fracture risk? J Clin Endocrinol Metab. 2001;86(1):29-31.

Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Yet al. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab. 1997;82(9):2915-20.

Koshiyama H, Wada Y, Nakamura Y. Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus. Arch Intern Med. 2001;161(13):1678-9.

D’Amelio P, Pescarmona GP, Gariboldi A, Ġsaia GC. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: A preliminary study. Menopause. 2003;8(6):429-32.

Hyasaat D, Alyan T, Jaddou H, Ajlouni KM. Prevalence and risk factors of osteoporosis among jordanian postmenopausal women attending the national center for diabetes, endocrinology and genetics in Jordan. BioRes Open Access. 2017;6(1):85-93.

Botella Martínez S, Varo Cenarruzabeitia N, Escalada San Martin J, Calleja Canelas A. La paradoja diabética: densidad mineral ósea y fractura en la diabetes tipo 2. Endocrinol Nutr. 2016;63(9):495-501.

Yamaguchi T. Bone fragility in type 2 diabetes mellitus. World J Orthop. 2010;1(1):3-9.

Choi YJ, Yang SO, Shin CS, Chung YS. The importance of morphometric radiographic vertebral assessment for the detection of patients who need pharmacological treatment of osteoporosis among postmenopausal diabetic Korean women. Osteoporos Int. 2012;23(8):2099-105.

Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res. 2009;24(4):702-9.

Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano, S, Sugimoto, T. Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporosis Int. 2007;18(12):1675-81.

Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2009;84(1):45-55.

Ardawi MS, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone. 2013;56(2):355-62.

Yamamoto M, Yamauchi M, Sugimoto T. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2013;98(10):4030-7.